Nephrotic‑Range Proteinuria in Pregnancy: Evidence‑Based Guideline Summary
Epidemiology
- Approximately 20 % of pregnancies complicated by preeclampsia occur on a background of previously undiagnosed chronic kidney disease, highlighting the need to consider underlying renal pathology when evaluating proteinuria. 3
Diagnostic Criteria
- Massive proteinuria (>5 g/24 h) in the setting of preeclampsia correlates with more severe neonatal outcomes and earlier delivery, underscoring its prognostic significance. [1][2]
- Gestational proteinuria is defined as new‑onset proteinuria without accompanying hypertension, edema, or other features of preeclampsia or primary renal disease. [4][5]
- Women with gestational proteinuria exhibit placental growth factor concentrations that are intermediate between normal pregnancies and preeclampsia, suggesting it may represent an early stage of preeclampsia. 4
- Proteinuria that appears after 20 weeks’ gestation together with hypertension strongly points toward a diagnosis of preeclampsia. 4
- A spot urine protein‑to‑creatinine ratio exceeding 900 mg/mmol (or >500 mg/mmol in patients >35 years) is linked to poorer maternal outcomes, supporting its use as a rapid screening tool. 1
- A 24‑hour urine collection remains the gold standard for confirming nephrotic syndrome in pregnancy, which has implications for decisions regarding thromboprophylaxis. [4][2]
Prognostic Implications
- In pregnancies with preeclampsia, massive proteinuria (>5 g/24 h) is associated with earlier gestational age at delivery and increased neonatal morbidity. [1][2]
Management Recommendations
- When nephrotic‑range proteinuria is identified, clinicians should consider three potential trajectories:
Postpartum Follow‑Up
- If proteinuria or hypertension persist between 4 and 12 weeks after delivery, referral for further evaluation—including consideration of a kidney biopsy—is recommended to exclude underlying renal disease. 3
- Proteinuria should be re‑assessed at 3 months postpartum even when initial resolution is observed, to detect delayed or persistent renal involvement. [4][5]
- Annual medical reviews for at least 5–10 years postpartum are advised because of the heightened long‑term risk for cardiovascular and chronic kidney disease. 3